19200 
Federal Register / Voi.- 59, No. 78 '/ Friday, April 22, 1994 ■/ Notices 
This meeting will be open to the 
public on June 29 from 8:30 a.m. to 10 
a.m. Agenda items to be discussed will 
include a Report from the Director, 
NINR; an Achninistrative Report by the 
Scientific Review Administrator, and 
consideration of future meeting dates. 
In accordance with the provisions set 
forth in sections 552b(c)(4) and 
552b(c)(6), title 5, U.S. Code and section 
10(d) of Fhblic Law 92-463, the meeting 
will be closed to the public on June 29 
from 10 a.m. to adjournment on June 30 
for the review, discussion, and 
evaluation of individual grant 
applications. The applications and the 
discussions could reveal confidential 
trade secrets or commercial property 
such as patentable material, and 
personal information concerning 
individuals associated with the 
applications, the disclosure of which 
would constitute a clearly unwarranted 
invasion of personal privacy. 
Individuals who plan to attend and 
need special assistance, such as sign 
language interpretation or other 
reasonable accommodations, should 
contract Dr. Ernest Marquez 301-594- 
7865 in advance of the meeting. 
Dr. Mary Stephens-Frazier, Scientific 
Review Administrator, Nursing Science 
Review Section, National Institute of 
Nursing Research, National Institutes of 
Health, Westwood Building, room 740, 
Bethesda, Maryland 20892, (301) 594— 
7865, will provide a summary of the 
meeting, and a roster of committee 
members upon request. I 
(Catalog of Federal Domestic Assistance 
Program No. 93.361, Nursing Research, 
National Institutes of Health.) 
Dated: April 18, 1994. 
Susan K. Feldman, 
Committee Management Officer, N/H. 
(FR Doc. 94-9778 Filed 4-21-94, 8.45 am| 
aiLUNG COOC 4140-01-M 
National Library of Medicine; Meeting 
of the Literature Selection Technical 
Review Committee 
Pursuant to Public Law 92—463, 
notice is hereby given of a meeting of 
the Literature Election Technical 
Review Committee, National Library of 
Medicine, on June 2-3, 1994, convening 
at 9 a.m. on June 2 and at 8:30 a.m. on 
June 3 in the Board Room of the 
National Library of Medicine, Building 
38, 8600 Rockville Pike, Bethesda, 
Maryland. 
Tne meeting on June 2 will be open 
to the public from 9 a m. to 
approximately 11 a.m. for the 
discussion of administrative reports and 
program developments. Attendance by 
the public will be limited to space 
available. Individuals who plan to 
attend and need special assistance, such 
as sign language interpretation or other 
reasonable accommodations, should 
contact Ms. Karen Griffin at 301-496- 
6921 two weeks before the meeting. 
In accordance with provisions set 
forth in section 552b(c)(9)(B), Title 5, 
U.S.C., Public Law 92—463, the meeting 
will be closed on June 2^ from 11 a.m. 
to approximately 5 p.m. and on June 3 
from 8:30 ajn. to adjournment for the 
review and discussion of individual 
journals as potential titles to be indexed 
by the National Library of Medicine. 
The presence of individuals associated 
with these publications could hinder 
fair and open discussion and evaluation 
of individual journals by the Committee 
members. 
Mrs. Lois Ann Colaianni, Scientific 
Review Administrator of the Committee, 
and Associate Director, Library 
Operations, National Library of 
Medicine, 8600 Rockville Pike, 
Bethesda, Maryland 20894, telephone 
number 301—496-5921, will provide a 
summary of the meeting, rosters of the 
committee members, and other 
information pertaining to the meeting. 
Dated: April 18, 1994. 
Susan K. Feldman, 
Committee Management Officer. NIH. 
(FR Doc. 94-9775 Filed 4-21-94: 8:45 am) 
BILLING cooe 414I>-01-M 
Recombinant DNA Advisory 
Committee; Meeting 
Pursuant to Public Law 92—463, 
notice is hereby given of a meeting of 
the Recombinant DNA Advisory 
Committee on June 9-10, 1994. The 
meeting will be held at the National 
Institutes of Health, Building 3lC, 6th 
Floor, Conference Room 6, 9000 
Rockville Pike, Bethesda, Maryland 
20892, starting at approximately 9 a.m. 
on June 9, 1994, to adjournment at 
approximately 5 p.m. on June 10, 1994. 
The meeting will be open to the public 
to discuss Ffroposed Actions under the 
NIH Guidelines for Research Involving 
Recombinant DNA Molecules (51 FR 
16958) and other matters to be 
considered by the Committee. The 
Proposed Actions to be discussed will 
follow this notice of meeting. 
Attendance by the public will be 
limited to space available. Members of 
the public wishing to speak at this 
meeting may be given such opportunity 
at the discretion of the Chair. 
Dr. Nelson A. Wivel, Director, Office 
of Recombinant DNA Activities, 
National Institutes of Health, Building 
31, room 4Bll, Bethesda, Maryland 
20892, Phone (301) 496-9838, FAX 
(301) 496—9839, wil) provide materials 
to be discussed at this meeting, roster of 
committee members, and substantive 
program information. Individuals who. 
plan to attend apd need special 
assistance, such as sign language 
interpretation or other reasonable 
accommodations, should contact Dr. 
Wivel in advance of the meeting. A 
summary of the meeting will tfe 
available at a later date. 
OMB’s "Mandatory Information 
Requirements for Federal Assistance 
Program Announcements" (45 FR 
39592, June 11, 1980) requires a 
statement concerning the official 
government programs contained in the 
Catalog of F^eral Domestic Assistance. 
Normally NIH lists in its 
announcements the number and title of 
affected individual programs for the 
guidance of the public. Because the 
guidance in this notice covers not only 
virtually every NIH program but also 
essentially every Federd research 
program in which DNA recombinant 
molecule techniques could be used, it 
has been determined not to be cost 
effective or in the public interest to 
attempt to list these programs. Such a 
list would likely require several 
additional pages. In addition, NIH could 
not be certain that every Federal 
program would be included as many 
Federal agencies, as well as private 
organizations, both national and 
international, have elected to follow the 
NIH Guidelines. In lieu of the 
individual program listing, NIH invites 
readers to direct questions to the 
information address above about 
whether individual programs listed in 
the Catalog of Federal Domestic 
Assistance are affected. 
Dated: April 18, 1994. 
Susan K. Feldman, 
Committee Management Officer, NIH. 
[FR Doc. 94-9789 Filed 4-21-94; 8:45 aip) 
BILUNQ CODE 4140-01-M - . 
National Institutes of Health (NIH); 
Meeting of Panel/Request for Public 
Comment 
The fourth meeting of the National 
Institutes of Health (NIH) Human 
Embryo Research Panel will be held 
May 3—4 from 9 a.m. to 5 p.m. each day 
at the Holiday Inn Bethesda, 8120 
Wisconsin Avenue, Bethesda, Maryland. 
The Panel is a group of special 
consultants to the Advisory Committee 
to the Director (ACD), NIH, established 
to recommend guidelines for Federal 
funding of research involving the ex 
utero human embryo resulting from in 
vitro fertilization or other sources 
[ 298 ] 
Recombinant DNA Research, Volume 19 
